557 Determining the efficacy of ADCC by the 3D-EX ex vivo platform utilizing tumoroids of fresh patient tumor samples with intact tumor microenvironment

• Katrina Hawley,
• Rachel Eclov,
• Marie Fefferman,
• Gregory Bird,
• Mathew Schnorenberg,
• Ravand Samaeekia,
• Loren Walensky,
• Matthew Tirrell,
• James LaBelle

Affiliations

Katrina Hawley

1University of Chicago, Chicago, IL, USA

Rachel Eclov

1University of Chicago, Chicago, IL, USA

Marie Fefferman

1University of Chicago, Chicago, IL, USA

Gregory Bird

2Dana-Farber Cancer Institute, Boston, MA, USA

Mathew Schnorenberg

1University of Chicago, Chicago, IL, USA

Ravand Samaeekia

1University of Chicago, Chicago, IL, USA

Loren Walensky

2Dana-Farber Cancer Institute, Boston, MA, USA

Matthew Tirrell

1University of Chicago, Chicago, IL, USA

James LaBelle

1University of Chicago, Chicago, IL, USA